Abstract
Imaging continues to have a huge impact on the understanding of the ischemic penumbra and the management of acute stroke. Determinants of penumbral tissue fate, such as age, hyperglycemia, hematocrit, and oxygen concentration, are increasingly being recognized using neuroimaging. The significance of the penumbra in the white matter and in posterior circulation stroke is also becoming clearer. Neuroimaging is also making invaluable contributions to clinical decision making in acute stroke, especially in relation to reperfusion therapies in the 3- to 6-hour time window. Despite ongoing questions over the choice of parameters to identify the penumbra and their respective clinical usefulness, imaging is gaining widespread use in acute stroke management. However, definitive evidence of its benefit is still lacking. This review explores the recent progress and controversies relating to imaging of the penumbra.
Similar content being viewed by others
References and Recommended Reading
Astrup J, Siesjo BK, Symon L: Thresholds in cerebral ischemia—the ischemic penumbra. Stroke 1981, 12:723–725.
Baron JC: Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis 2001, 11(Suppl 1):2–8.
Dewar D, Yam P, McCulloch J: Drug development for stroke: importance of protecting cerebral white matter. Eur J Pharmacol 1999, 375:41–50.
Falcao AL, Reutens DC, Markus R, et al.: The resistance to ischemia of white and gray matter after stroke. Ann Neurol 2004, 56:695–701.
Koga M, Reutens DC, Wright P, et al.: The existence and evolution of diffusion-perfusion mismatched tissue in white and gray matter after acute stroke. Stroke 2005, 36:2132–2137.
Simon JE, Bristow MS, Lu H, et al.: A novel method to derive separate gray and white matter cerebral blood flow measures from MR imaging of acute ischemic stroke patients. J Cereb Blood Flow Metab 2005, 25:1236–1243.
Bristow MS, Simon JE, Brown RA, et al.: MR perfusion and diffusion in acute ischemic stroke: human gray and white matter have different thresholds for infarction. J Cereb Blood Flow Metab 2005, 25:1280–1287.
Ostrem JL, Saver JL, Alger JR, et al.: Acute basilar artery occlusion: diffusion-perfusion MRI characterization of tissue salvage in patients receiving intra-arterial stroke therapies. Stroke 2004, 35:e30–34.
Montavont A, Nighoghossian N, Derex L, et al.: Intravenous r-TPA in vertebrobasilar acute infarcts. Neurology 2004, 62:1854–1856.
Pialat JB, Wiart M, Nighoghossian N, et al.: Evolution of lesion volume in acute stroke treated by intravenous t-PA. J Magn Reson Imaging 2005, 22:23–28.
Weimar C, Konig IR, Kraywinkel K, et al.: Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models. Stroke 2004, 35:158–162.
Bruno A, Biller J, Adams HP Jr, et al.: Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999, 52:280–284.
Gagnon DR, Zhang TJ, Brand FN, Kannel WB: Hematocrit and the risk of cardiovascular disease—the Framingham study: a 34-year follow-up. Am Heart J 1994, 127:674–682.
Parsons MW, Barber PA, Desmond PM, et al.: Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002, 52:20–28.
Baird TA, Parsons MW, Phanh T, et al.: Persistent post-stroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003, 34:2208–2214.
Garg R, Chaudhuri A, Munschauer F, Dandona P: Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke 2006, 37:267–273.
Ay H, Koroshetz WJ, Vangel M, et al.: Conversion of ischemic brain tissue into infarction increases with age. Stroke 2005, 36:2632–2636.
Allport LE, Parsons MW, Butcher KS, et al.: Elevated hematocrit is associated with reduced reperfusion and tissue survival in acute stroke. Neurology 2005, 65:1382–1387.
Singhal AB, Benner T, Roccatagliata L, et al.: A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke 2005, 36:797–802.
Nakajima S, Meyer JS, Amano T, et al.: Cerebral vasomotor responsiveness during 100% oxygen inhalation in cerebral ischemia. Arch Neurol 1983, 40:271–276.
Rusyniak DE, Kirk MA, May JD, et al.: Hyperbaric oxygen therapy in acute ischemic stroke: results of the Hyperbaric Oxygen in Acute Ischemic Stroke Trial Pilot Study. Stroke 2003, 34:571–574.
Fiehler J, Remmele C, Kucinski T, et al.: Reperfusion after severe local perfusion deficit precedes hemorrhagic transformation: an MRI study in acute stroke patients. Cerebrovasc Dis 2005, 19:117–124.
Selim M, Fink JN, Kumar S, et al.: Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke 2002, 33:2047–2052.
Alsop DC, Makovetskaya E, Kumar S, et al.: Markedly reduced apparent blood volume on bolus contrast magnetic resonance imaging as a predictor of hemorrhage after thrombolytic therapy for acute ischemic stroke. Stroke 2005, 36:746–750.
Latour LL, Kang DW, Ezzeddine MA, et al.: Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol 2004, 56:468–477.
Warach S, Latour LL: Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke 2004, 35:2659–2661.
Hjort N, Christensen S, Solling C, et al.: Ischemic injury detected by diffusion imaging 11 minutes after stroke. Ann Neurol 2005, 58:462–465.
Lin W, Lee JM, Lee YZ, et al.: Temporal relationship between apparent diffusion coefficient and absolute measurements of cerebral blood flow in acute stroke patients. Stroke 2003, 34:64–70.
Hamon M, Marie RM, Clochon P, et al.: Quantitative relationships between ADC and perfusion changes in acute ischemic stroke using combined diffusion-weighted imaging and perfusion MR (DWI/PMR). J Neuroradiol 2005, 32:118–124.
Nicoli F, Lefur Y, Denis B, et al.: Metabolic counterpart of decreased apparent diffusion coefficient during hyperacute ischemic stroke: a brain proton magnetic resonance spectroscopic imaging study. Stroke 2003, 34:e82–87.
Guadagno JV, Warburton EA, Jones PS, et al.: The diffusion-weighted lesion in acute stroke: heterogeneous patterns of flow/metabolism uncoupling as assessed by quantitative positron emission tomography. Cerebrovasc Dis 2005, 19:239–246.
Guadagno JV, Warburton EA, Aigbirhio FI, et al.: Does the acute diffusion-weighted imaging lesion represent penumbra as well as core? A combined quantitative PET/MRI voxel-based study. J Cereb Blood Flow Metab 2004, 24:1249–1254.
Loh PS, Butcher KS, Parsons MW, et al.: Apparent diffusion coefficient thresholds do not predict the response to acute stroke thrombolysis. Stroke 2005, 36:2626–2631.
Kidwell CS, Saver JL, Mattiello J, et al.: Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 2000, 47:462–469.
Fiehler J, Knudsen K, Kucinski T, et al.: Predictors of apparent diffusion coefficient normalization in stroke patients. Stroke 2004, 35:514–519.
Suzuki S, Kidwell CS, Starkman S, et al.: Use of multimodal MRI and novel endovascular therapies in a patient ineligible for intravenous tissue plasminogen activator. Stroke 2005, 36:e77–79.
Chalela JA, Kang DW, Luby M, et al.: Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: Insights into the pathophysiology of acute stroke in the thrombolysis era. Ann Neurol 2004, 55:105–112.
Rivers CS, Wardlaw JM: What has diffusion imaging in animals told us about diffusion imaging in patients with ischaemic stroke? Cerebrovasc Dis 2005, 19:328–336.
Kidwell CS, Saver JL, Starkman S, et al.: Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol 2002, 52:698–703.
Thijs VN, Somford DM, Bammer R, et al.: Influence of arterial input function on hypoperfusion volumes measured with perfusion-weighted imaging. Stroke 2004, 35:94–98.
Rose SE, Janke AL, Griffin M, et al.: Improved prediction of final infarct volume using bolus delay-corrected perfusion-weighted MRI: implications for the ischemic penumbra. Stroke 2004, 35:2466–2471.
Wu O, Ostergaard L, Koroshetz WJ, et al.: Effects of tracer arrival time on flow estimates in MR perfusion-weighted imaging. Magn Reson Med 2003, 50:856–864.
Sobesky J, Zaro Weber O, Lehnhardt FG, et al.: Which time-to-peak threshold best identifies penumbral flow? A comparison of perfusion-weighted magnetic resonance imaging and positron emission tomography in acute ischemic stroke. Stroke 2004, 35:2843–2847.
Grandin CB, Duprez TP, Smith AM, et al.: Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements. Radiology 2002, 223:361–370.
Butcher KS, Parsons M, MacGregor L, et al.: Refining the perfusion-diffusion mismatch hypothesis. Stroke 2005, 36:1153–1159.
Schellinger PD, Latour LL, Wu CS, et al.: The association between neurological deficit in acute ischemic stroke and mean transit time Comparison of four different perfusion MRI algorithms. Neuroradiology 2005, 47:1–9.
Lee DH, Kang DW, Ahn JS, et al.: Imaging of the ischemic penumbra in acute stroke. Korean J Radiol 2005, 6:64–74.
Perkio J, Soinne L, Ostergaard L, et al.: Abnormal intravoxel cerebral blood flow heterogeneity in human ischemic stroke determined by dynamic susceptibility contrast magnetic resonance imaging. Stroke 2005, 36:44–49.
Sobesky J, Zaro Weber O, Lehnhardt FG, et al.: Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke 2005, 36:980–985.
Heiss WD, Sobesky J, Hesselmann V: Identifying thresholds for penumbra and irreversible tissue damage. Stroke 2004, 35:2671–2674.
Kang DW, Chalela JA, Dunn W, Warach S: MRI screening before standard tissue plasminogen activator therapy is feasible and safe. Stroke 2005, 36:1939–1943.
Schellinger PD, Jansen O, Fiebach JB, et al.: Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia. Am J Neuroradiol 2000, 21:1184–1189.
U-King-Im JM, Trivedi RA, Graves MJ, et al.: Utility of an ultrafast magnetic resonance imaging protocol in recent and semi-recent strokes. J Neurol Neurosurg Psychiatry 2005, 76:1002–1005.
Kidwell CS, Chalela JA, Saver JL, et al.: Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004, 292:1823–1830.
Hjort N, Butcher K, Davis SM, et al.: Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke 2005, 36:388–397.
Hacke W, Albers G, Al-Rawi Y, et al.: The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intraveous desmoteplase. Stroke 2005, 36:66–73.
Ribo M, Molina CA, Rovira A, et al.: Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke 2005, 36:602–606.
Singer OC, Du Mesnil De Rochemont R, et al.: Early functional recovery and the fate of the diffusion/perfusion mismatch in patients with proximal middle cerebral artery occlusion. Cerebrovasc Dis 2004, 17:13–20.
Wintermark M, Sesay M, Barbier E, et al.: Comparative overview of brain perfusion imaging techniques. Stroke 2005, 36:e83–99.
Mayer TE, Hamann GF, Baranczyk J, et al.: Dynamic CT perfusion imaging of acute stroke. Am J Neuroradiol 2000, 21:1441–1449.
Schramm P, Schellinger PD, Klotz E, et al.: Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with acute stroke of less than 6 hours’ duration. Stroke 2004, 35:1652–1658.
Wintermark M, Fischbein NJ, Smith WS, et al.: Accuracy of dynamic perfusion CT with deconvolution in detecting acute hemispheric stroke. Am J Neuroradiol 2005, 26:104–112.
Muir KW, Halbert HM, Baird TA, et al.: Visual evaluation of perfusion CT imaging in acute stroke accurately estimates infarct volume and tissue viability. J Neurol Neurosurg Psychiatry 2006, 77:334–339.
Fiorella D, Heiserman J, Prenger E, Partovi S: Assessment of the reproducibility of postprocessing dynamic CT perfusion data. Am J Neuroradiol 2004, 25:97–107.
Wintermark M, Reichhart M, Thiran JP, et al.: Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 2002, 51:417–432.
Wintermark M, Reichhart M, Cuisenaire O, et al.: Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke 2002, 33:2025–2031.
Hellier KD, Hampton JL, Guadagno JV, et al.: Perfusion CT helps decision making for thrombolysis when there is no clear time of onset. J Neurol Neurosurg Psychiatry 2006, In press.
Davalos A, Blanco M, Pedraza S, et al.: The clinical-DWI mismatch: a new diagnostic approach to the brain tissue at risk of infarction. Neurology 2004, 62:2187–2192.
Prosser J, Butcher K, Allport L, et al.: Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke 2005, 36:1700–1704.
Kent DM, Hill MD, Ruthazer R, et al.: "Clinical-CT mismatch" and the response to systemic thrombolytic therapy in acute ischemic stroke. Stroke 2005, 36:1695–1699.
Butcher K, Lee SB, Parsons M, et al.: Increased blood volume maintains viability in tissue with isolated focal swelling on CT in acute stroke. Stroke 2005, 36:418.
Markus R, Reutens DC, Kazui S, et al.: Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous survival. Brain 2004, 127:1427–1436.
Lee JM, Vo KD, An H, et al.: Magnetic resonance cerebral metabolic rate of oxygen utilization in hyperacute stroke patients. Ann Neurol 2003, 53:227–232.
Walker PM, Ben Salem D, Lalande A, et al.: Time course of NAA T2 and ADC(w) in ischaemic stroke patients: 1H MRS imaging and diffusion-weighted MRI. J Neurol Sci 2004, 220:23–28.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moustafa, R.R., Baron, JC. Imaging the penumbra in acute stroke. Curr Atheroscler Rep 8, 281–289 (2006). https://doi.org/10.1007/s11883-006-0005-0
Issue Date:
DOI: https://doi.org/10.1007/s11883-006-0005-0